Back
Health Catalyst Quote, Financials, Valuation and Earnings
Sponsored
HCAT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
HCAT
Health Catalyst
Last Price:
8.14
Seasonality Move:
11.46%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Health Catalyst Price Quote
$8.14
+0.01 (+6.27%)
(Updated: November 23, 2024 at 5:38 AM ET)
Health Catalyst Key Stats
Buy
54
Health Catalyst (HCAT)
is a Buy
Day range:
$7.67 - $8.25
52-week range:
$5.42 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.59
P/B ratio:
1.39%
Volume:
492.2K
Avg. volume:
529.1K
1-year change:
5.31%
Market cap:
$494.7M
Revenue:
$295.9M
EPS:
$-1.35
How Much Does Health Catalyst Make?
-
How Much Are Health Catalyst's Sales Annually?
HCAT Revenues are $295.9M -
How Much Profit Does Health Catalyst's Make A Year?
HCAT net income is -$118.1M
Is Health Catalyst Growing As A Company?
-
What Is Health Catalyst's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.03% -
What Is Health Catalyst's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Health Catalyst Stock Price Performance
-
Did Health Catalyst Stock Go Up Last Month?
Health Catalyst share price went down by -5.79% last month -
Did HCAT's Share Price Rise Over The Last Year?
HCAT share price rose by 5.31% over the past 1 year
What Is Health Catalyst 52-Week High & Low?
-
What Is Health Catalyst’s 52-Week High Share Price?
Health Catalyst has traded as high as $11.41 over the past 52 weeks -
What Is Health Catalyst’s 52-Week Low Share Price?
Health Catalyst has traded as low as $5.42 over the past 52 weeks
Health Catalyst Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Health Catalyst?
-
How Much Debt Does Health Catalyst Have?
Total long term debt quarterly is $345M -
How Much Cash Does Health Catalyst Have?
Cash and short term investments quarterly total is $387.3M -
What Is Health Catalyst’s Book Value Per Share?
Book value per share is 5.83
Is Health Catalyst Cash Flow Positive?
-
What Is HCAT Cash Flow From Operations?
Cash flow from operations (TTM) is -$955K -
What Is Health Catalyst’s Cash Flow From Financing?
Cash flow from financing (TTM) is $114.5M -
What Is Health Catalyst’s Cash Flow From Investing?
Cash flow from investing (TTM) is $119.8M
Health Catalyst Return On Invested Capital
-
Is Management Doing A Good Job?
HCAT return on invested capital is -12.86% -
What Is Health Catalyst Return On Assets?
ROA measures how assets are converting to revenues and is -10.95% -
What Is HCAT Return On Equity?
ROE is a measure of profitability and is -21.76%
Health Catalyst Earnings Date & Stock Price
-
What Is Health Catalyst's Stock Price Today?
A single share of HCAT can be purchased today for 8.13 -
What Is Health Catalyst’s Stock Symbol?
Health Catalyst trades on the nasdaq under the ticker symbol: HCAT -
When Is Health Catalyst’s Next Earnings Date?
The next quarterly earnings date for Health Catalyst is scheduled on February 21, 2025 -
When Is HCAT's next ex-dividend date?
Health Catalyst's next ex-dividend date is November 25, 2024 -
How To Buy Health Catalyst Stock?
You can buy Health Catalyst shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Health Catalyst Competitors
-
Who Are Health Catalyst's Competitors?
Below is a list of companies who compete with Health Catalyst or are related in some way:
Health Catalyst Dividend Yield
-
What Is HCAT Dividend Yield?
Health Catalyst’s dividend yield currently is 0% -
What Is Health Catalyst’s Payout Ratio?
Health Catalyst’s payout ratio is 0% -
When Did Health Catalyst Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Health Catalyst’s Dividend Per Share?
Health Catalyst pays a dividend of $0.00 per share
Health Catalyst Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -25.42% |
Revenue: | 3.5% | -0.13% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 0 |
Price Target: | 11.54 |
Upside from Last Price: | 41.96% |